Showing results (71-80 of 4,015) with videos related to
Sort By:
Pageof 402
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|June 20, 2001
[Insulin resistance-reducing effect of a new thiazolidinedione derivative, pioglitazone]H Ikeda, Y SugiyamaJournal of Biochemistry|May 1, 1994
Archae-opsin expressed in Escherichia coli and its conversion to purple pigment in vitroY Sugiyama, Y MukohataYakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 1, 1994
[Kinetic analysis of the disposition of hydrophilic drugs in the central nervous system (CNS): prediction of the CNS disposition from the transport properties in the blood-brain and blood-cerebrospinal fluid barriers]H Suzuki, Y SugiyamaThe Journal of Pharmacology and Experimental Therapeutics|March 13, 1998
Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonistH Imawaka, Y SugiyamaSeminars in Liver Disease|January 6, 1999
Excretion of GSSG and glutathione conjugates mediated by MRP1 and cMOAT/MRP2H Suzuki, Y SugiyamaJournal of Pharmacokinetics and Biopharmaceutics|April 17, 1999
Analysis of nonlinear and nonsteady state hepatic extraction with the dispersion model using the finite difference methodA Hisaka, Y SugiyamaSeminars in Liver Disease|November 15, 2000
Transport of drugs across the hepatic sinusoidal membrane: sinusoidal drug influx and efflux in the liverH Suzuki, Y SugiyamaDrug Discovery Today|February 15, 2001
Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 2)H Kusuhara, Y SugiyamaNihon Rinsho. Japanese Journal of Clinical Medicine|November 20, 2001
[Pharmacological effects of a thiazolidinedione derivative, pioglitazone]H Ikeda, Y SugiyamaThe International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 28, 2001
Elevated soluble CD26 levels in patients with tuberculous pleurisyK Oshikawa, Y SugiyamaPageof 402